Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Clinerion, Maxer Consulting partner to boost identification and recruitment of patients into clinical trials in Italy, promoting safer, more effective clinical outcomes


Clinerion and Maxer will cooperate to engage clinical trial sponsors to fully exploit Patient Network Explorer’s potential and provide added-value services arising from Maxer’s experience in clinical data management, regulatory affairs, medical affairs, clinical trial disclosure and data transparency, and medical writing services.

The partners’ joint mission is to liaise with study sites to increase patient participation in trials to its full potential by offering tools to optimize protocol design, supporting the efficient start-up of local trials, and planning and consistently hitting realistic patient recruitment targets to enable the achievement of total timeline targets.

Clinerion makes real-world patient data accessible for analysis so that study protocols can be optimized with real patients in mind. It also maintains a cloud platform that brings together participants from across the clinical study ecosystem, comprising sponsors, hospitals and clinicians, and treating physicians and patients.

Maxer will support commercial and non-commercial sponsors in registering their clinical trials, uploading the results of the clinical trials on the public databases (EU and US), anonymizing the clinical data, and editing relevant scientific papers.

The geographic scope of the partnership is primarily focused on Italy, but will extend to other countries as opportunities arise.

“There are objective complementarities between Clinerion’s and Maxer’s business models,” says Massimo Zaninelli, CEO Of Maxer. “This condition lays the foundations for cooperation that will contribute to carrying out clinical studies on targeted patient populations, reducing the times and costs of implementation, and enabling innovative approaches to personalized medicine.”

“We are eager to bring the full support of our services to the patients and physicians in Italy,” says Ian Rentsch, CEO of Clinerion. “Clinerion’s Patient Network Explorer matches patients to clinical research, creating greater access to international trials for Italian trial sites and offering physicians more treatment options.”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.

Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/PatientNetworkExplorerSolutions.html

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

About Maxer Consulting

Maxer applies its pharmaceutical expertise, medical communication techniques, change management method, and training programmes to help its customers meet the continually increasing expectations for new therapeutic solutions.

Maxer business model is based on interacting with its customers in an open, collaborative, and proactive way with high standards of quality. Putting people at the centre does apply to both patients and the principle of responsibility that is part of any entrepreneurial initiative.

The creation of economic and social value is Maxer’s purpose and ensures the independence that allows operating successfully.

The constant quest for innovation guarantees that Maxer provides its clients with the most advanced solutions.

Maxer Consulting website: http://www.maxerconsulting.it/en

For more information, please contact:

Erika Ornago

Pharma Director

Maxer Consulting srl

Via Leon Battista Alberti, 5

20149 Milan – Italy

Tel.: +39 83421186

info@maxerconsulting.com

Share article on social media or email:

NuLiv Science Launches Senactiv®, a Sport Nutraceutical Ingredient


We have now found a way to slow down muscle aging… and we know muscle strength and muscle mass is an important indicator of healthy aging for consumers – Richard Wang, President

NuLiv Science announced today the launch of its newly rebranded sports nutraceutical compound, Senactiv®.

The ingredient, formerly known as ActiGin®, is scientifically validated with 6 human clinical studies to enhance physical performance through energy nourishment and optimized cell turnover specifically in exercised muscle tissue.

Along with a new clinical study featured this summer in the journal, Aging, Senactiv® is uniquely positioned to be a catalyst for boosting human performance in the context of healthy aging and exercise.

“With our newest research on senescent cell clearance in exercised muscle tissue and our research plan for the future we felt it was a great time to reposition and refresh the brand of this incredible ingredient”, shared Josh Beaty, Marketing Director. “Muscle Energy and muscle regeneration are the key value propositions, and we know consumers are actively seeking these outcomes.”

New research means innovation ahead for supplement product formulators.

NuLiv Science President, Richard Wang added, “We have now found a way to slow down muscle aging… and we know muscle strength and muscle mass is an important indicator of healthy aging for consumers”.

The ingredient is available and product formulators are encouraged to visit the company’s website to get more information.

NuLiv Science specializes in the research and development of proprietary and clinically proven nutraceutical ingredients via traditional and scientific processes. Since 1997, the company has served customers’ sourcing and research needs with an emphasis on quality and efficacy.

Share article on social media or email:

Mindray North America Announces Strategic Collaboration with Amazon Business


As a manufacturer dedicated solely to the medical industry, Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus and we continue to shift our organizational focus toward doing just this.

Mindray North America is pleased to announce a strategic collaboration with Amazon Business that will provide healthcare systems, hospitals and clinicians immediate and direct access to a broad range of Mindray’s innovative, category-leading patient monitoring, anesthesia and ultrasound imaging products, and associated accessories.

With the U.S. still in the grip of the COVID-19 pandemic, immediate access to essential medical devices used in the diagnosis, monitoring and support of critically ill patients has never been at a more urgent level. With Amazon’s demonstrated operational efficiency to effectively compress the expired time between an order and delivery, intuitive front-end, online ordering capability, and commitment to a significant and meaningful upfront investment in inventory, the decision was an obvious one.

“We are ecstatic to begin this crucial relationship with Amazon Business”, stated Wayne Quinn, President, Mindray North America. “This partnership embodies Mindray’s global vision and mission to provide better healthcare for all and advance medical technologies to make healthcare more accessible. As a manufacturer dedicated solely to the medical industry, Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus and we continue to shift our organizational focus toward doing just this.”

Mindray’s storefront on Amazon Business (https://www.amazon.com/stores/page/83053634-350C-45D6-BE00-088F8AF66F0D) will feature Mindray’s configured Passport 8 and Passport 12 Patient Monitors, category-leading Accutorr 7 Spot Check Vital Signs Monitor, Advanced A7 and A5 Advantage Anesthesia Workstations and the M7 Premium Ultrasound System.

To see more regarding Mindray North America’s response to the COVID-19 Pandemic please visit our COVID-19 response page – https://www.mindraynorthamerica.com/covid-19-response/.

About Mindray

Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

Media Stream, LLC Launches WellnysDirect Online Search Directory to Support Wellness Professionals


online search directory

WellnysDirect Online Search Directory Launches

Unlike other directories, WellnysDirect offers wellness professionals full control to build their online presence. Everything is connected in one space,” says Charn Pennewaert, Founder and CEO of Media Stream, LLC

Media Stream, LLC will be launching WellnysDirect online platform to help wellness professionals and businesses connect with their digital audience on September 20, 2020. The Yelp-like platform allows wellness practitioners an opportunity to create a free profile on the search directory or choose an upgraded premium plan for more directory features.

Registered users are provided with a robust online profile to garner additional online traffic and improved SEO ranking. With a plethora of available features such as article highlights, video galleries, live testimonials and appointment links, it’s the closest thing to a website without the investment.

WellnysDirect is a natural progression from its partnership with Wellnys.com, a wellness news media site that launched last August in 2019. Currently, the technical team and web designers are working on adding advanced features and pre-loading the robust directory with profiles with categories that range from chiropractors, massage therapists to reiki masters.

Registered users of Wellnys Direct are given Contributor Access to Wellnys.com. As a Contributor, they can share their professional expertise in SEO-optimized articles, which can are back-linked to the individual’s website.

“Our goal with WellnysDirect is to provide wellness practitioners with an opportunity to build their online presence and showcase their specialties. Unlike other directories, WellnysDirect connects wellness professional to Wellnys.com where they are invited to share their expertise as contributors. Everything is connected in one space,” says Charn Pennewaert, Founder and CEO of Media Stream, LLC.

About Media Stream

Media Stream, LLC is a premier digital marketing and creative design agency based in Orange County, California. From small “Mom-and-Pops” to thriving corporations, Media Stream has crafted a myriad of successful projects for its clients, including custom websites, targeted advertisements and other creative assets.

Share article on social media or email:

MentalHappy Launches Equity Crowdfunding Campaign to Empower Women and Minorities to Invest


News Image

I decided to raise capital for MentalHappy through equity crowdfunding because it’s the only option available to founders like me who want to empower women, minorities and young people to take control of their wealth by giving them access to investment opportunities.

MentalHappy, a social network designed to help people improve their emotional wellbeing through positive peer support, announced today its equity crowdfunding campaign on StartEngine. MentalHappy, a startup backed by Y Combinator – one of the most respected startup accelerators in the U.S. – provides people with a safe and secure platform to talk about the challenges they face in their daily lives, receive support from peers who understand these stressors, and learn practical tips and techniques to help members heal and improve their emotional fitness each day.

“I chose to raise funding for MentalHappy through equity crowdfunding for one reason: inclusion,” said Tamar Blue, founder and CEO of MentalHappy. “I built our social network on the foundation of inclusion because we believe happiness and mental clarity are a right, not a privilege and that no one should be denied access to emotional wellness support because of high costs, limited access or because they feel uncomfortable talking about the tough issues with the people around them. This same principle applies when deciding who we allow to invest in our startup.”

Founders who don’t raise money through crowdfunding severely limit who can invest in their company. They are only able to accept investments from institutional investors, like venture capital firms, and from angel investors. Angel investors are individuals who are deemed as accredited, meaning they make $200,000 a year as an individual ($300,000 as a couple) or have a net worth over $1 million. Most angel investors are white men, with only a small percentage of women and minorities falling into that category. In fact, a study conducted by the Angel Capital Association and Wharton Entrepreneurship, shows that angel investors are 78 percent male, 87 percent white and their average age is 58. Only 22 percent of angel investors are women, less than 4 percent are black or hispanic and only 8 percent are 40 years old or younger.

Equity Crowdfunding: The Basics and SEC Requirements

With equity-based crowdfunding, members of the crowd become part-owners of the company that is raising funds. In other words, the company sells some or all of its shares to the members of the crowd. As equity owners of the company, the crowd realizes a return on its investment and receives a share of the profits in the form of a dividend or distribution. Prior to 2016, only three percent of Americans were legally allowed to invest in startups. Traditionally, investors were required to have a net worth of $1 million or earn $200K per year and the investment minimums started in the 5 or 6 figures. People who meet these requirements are known as “qualified investors.” Equity crowdfunding makes it possible for anyone to invest.

Unlike popular crowdfunding platforms used by individuals to secure donations, startups raising money through regulation crowdfunding (Reg CF) must undergo thorough vetting and meet stringent requirements from the U.S. Securities and Exchange Commission (SEC).

These requirements include:

  • Registering the company with the SEC
  • Thorough background checks on all officers of the company as part of the SEC’s anti-fraud regulations
  • Third-party fact checking of all data and claims made on the crowdfunding campaign page
  • Review of all financials by outside Certified Public Accountants (CPAs)
  • Regular reporting on how the company is allocating funding, which enables investors to have a clear view into how their dollars are being spent. Companies must also provide investors with products/service updates.
  • Providing investors with educational information on the investment risks

“In my mind, crowdfunding wasn’t optional,” said Blue. “Lack of inclusion is a leading cause of stress, anxiety and feelings of hopelessness — all of which MentalHappy is dedicated to helping people overcome,” said Blue. “I am part of the solution and cannot be part of the problem. I decided to raise capital for MentalHappy through equity crowdfunding because it’s the only option available to founders like me who want to empower women, minorities and young people to take control of their wealth by giving them access to investment opportunities.”

For more information on MentalHappy and its equity crowdfunding campaign, please visit: https://startengine.mentalhappy.com/prw.

About MentalHappy

MentalHappy is a social media network designed to help people improve their emotional wellbeing through positive peer support. This Y-Combinator-backed startup provides a safe and secure platform empowering people to talk about the challenges they face in their daily lives, receive support from peers who understand these stressors, and learn practical tips and techniques from licensed professionals. MentalHappy supports its members throughout every stage of their journey to emotional wellness:

1. Emotional Healing from difficult life events – from loss and injury to breakups and financial hardship.

2. Emotional Fitness aimed at reducing stress and developing inner strength.

3. Emotional Resilience helping you to be ready to respond to difficult moments in life.

For more information about MentalHappy, please check out our StartEngine campaign page and website, as well as connect with us on social media.

LinkedIn: linkedin.com/company/mentalhappy

Facebook: facebook.com/MentalHappyHumans

Twitter: twitter.com/MentalHappy

Instagram: instagram.com/MentalHappyLife

Share article on social media or email:



Genuine Health Group Names Jenifer Montesino Chief Operating Officer


Jenifer Montesino, COO of Genuine Health Group

Jenifer Montesino, COO of Genuine Health Group

Jeni has had a significant impact on our performance, generating substantial additional revenues […] while also increasing our quality scores.

Genuine Health Group, a Miami-based, integrated healthcare company that helps physicians navigate the industry’s transition to value-based care, announced Jenifer Montesino has been appointed the company’s chief operating officer. Ms. Montesino, who has been with Genuine Health for more than a year, previously served as vice president of revenue and quality.

In her new role, Ms. Montesino will oversee the day-to-day operations of the company, including revenue, quality, and physician engagement, as well as the Genuine Health At Home program, which provides home-based care for patients with chronic diseases, and the company’s home health agency.

“We are excited that Jenifer has accepted this new challenge as chief operating officer during this critical period of growth,” said Joe Caruncho, CEO of Genuine Health Group. “In the short time since she joined the Genuine team, Jeni has had a significant impact on our performance, generating substantial additional revenues by building a team to properly document our patients’ health status, while also increasing our quality scores. She is now ready to bring the same performance-oriented focus and energy to the company’s other operations.”

In her previous role, where she was responsible for quality improvement on behalf of the company’s hundreds of physicians, Ms. Montesino published the white paper, “Five Strategies To Improve Quality Measures,” in which she examines specific steps provider organizations can take to improve quality measures – measures that directly affect reimbursement and overall revenue.

“I have enjoyed the challenge of helping Genuine Health Group restructure and refine its revenue and quality operations over the past year,” said Jenifer Montesino. “I look forward to moving the company’s performance to the next level as we prepare to launch an aggressive growth strategy over the next year.”

Prior to joining Genuine Health Group, Ms. Montesino spent twelve years at UnitedHealthcare-owned and operated Medicare Advantage plans in Florida, where she concentrated on Medicare risk adjustment and overseeing primary care physicians’ quality ratings from the Centers for Medicare & Medicaid Services (CMS).

For more information about Genuine Health Group, to schedule an interview with Jenifer Montesino, or to read her white paper, please contact Meieli Sawyer at 305-668-0070 or msawyer@weinbachgroup.com.

About Genuine Health Group

Genuine Health Group is an analytics-driven healthcare company that assists physicians and health plans in successfully transitioning to value-based payment models.

Share article on social media or email:

Studies by AHN Neurologists Improve Understanding of Stroke Therapy Risks in Patients with Chronic Health Conditions


Konark Malhotra, MD, vascular neurologist at Allegheny General Hospital (AGH) and the AHN Neuroscience Institute, and principal investigator of the study

“Studies such as those led by Dr. Malhotra and his team are essential to improving our understanding of chronic disease management and developing better therapeutic strategies that can make a life-changing difference for stroke patients.”

Intravenous thrombolysis may put stroke patients with chronic kidney disease (CKD) at a higher risk for intracranial bleeding and mortality, according to a recent study published in the journal Neurology by researchers at the Allegheny Health Network (AHN) Neuroscience Institute. The study, “Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis,” surveyed various studies published across different countries and assessed the association of CKD among more than 60,000 acute ischemic stroke patients undergoing IV thrombolytic therapy.

According to the CDC, stroke kills about 140,000 Americans each year, accounting for approximately one out of every 20 deaths. Nearly 90 percent of strokes are classified as acute ischemic strokes which take place when a blood clot or narrowed artery obstructs blood flow to the brain. Within minutes, the lack of oxygenated blood to the brain can cause a severe, permanent neurological injury, and even death.

“Patients who suffer an acute ischemic stroke and arrive early to the hospital are often administered IV thrombolysis to dissolve dangerous clots in blood vessels, improve blood flow, and prevent damage to tissues and organs,” said Konark Malhotra, MD, vascular neurologist at Allegheny General Hospital (AGH) and the AHN Neuroscience Institute, and principal investigator of the study. “We wanted to better understand how this course of treatment with IV thrombolytic therapy may impact an already vulnerable population with a specific chronic condition like chronic kidney disease.”

In the systematic review, Dr. Malhotra and his colleagues evaluated outcomes with special attention being paid to intracranial bleeding, three-month mortality and functional independence rates with regard to a patient’s mobility and ability to maintain high levels of self-sufficiency.

Across 20 independent studies that were analyzed, a significant correlation was determined to exist between CKD and worsened clinical outcomes – most notably, a higher risk of intracranial bleeding and mortality.

“The primary causation of worsened outcomes presents an opportunity for further research. A likely contributing factor is the high rate of comorbidities seen in the study population; for example, hypertension and diabetes are the leading causes of chronic kidney disorder,” said Ashis Tayal, MD, neurologist and director of the AGH Stroke Center.

In addition to Dr. Malhotra and Dr. Tayal, other neurologists who contributed to the study include Aristeidis H. Katsanos, Nitin Goyal, Henrik Gensicke, Panayiotis D. Mitsias, Gian Marco De Marchis, Eivind Berge, Anne W. Alexandrov, Andrei V. Alexandrov and Georgios Tsivgoulis.

In another study published earlier this year in the AHA Journal of Hypertension, Dr. Malhotra’s team provided additional insight on how clinical outcomes of acute ischemic stroke patients who undergo stroke thrombectomy procedures are impacted by elevated blood pressure levels.

Dr. Malhotra performed a systematic review and pooled results from 25 published studies involving 6,500 patients who underwent acute stroke thrombectomy. This study analyzed the association of blood pressure – systolic and diastolic — before, during or after acute stroke thrombectomy with various clinical outcomes.

The authors found that higher blood pressure levels negatively affect stroke-related outcomes such as intracranial bleeding, death and functional independence in daily living.

“Studies such as those led by Dr. Malhotra and his team are essential to improving our understanding of chronic disease management and developing better therapeutic strategies that can make a life-changing difference for stroke patients,” continued Dr. Tayal.

AHN was recently recognized by the American Stroke Association for its excellence in stroke care. In August, the Network announced six Network hospitals earned Gold Plus Elite and Silver Plus designations for its adherence to guideline-directed therapies and protocols which in turn improves patient outcomes and decreases stroke recurrence rates.

For more information on the AHN Neuroscience Institute, visit http://www.ahn.org.

About the Allegheny Health Network:

Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 12 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Share article on social media or email:

Medicus Healthcare Solutions Announces New Executive Chairman & CEO


I’m highly encouraged with what I see in the Company’s future. The team is strong and I look forward to continuing to support the company as Executive Chairman.”

Medicus Healthcare Solutions (the Company) is pleased to announce the appointment of Joe Matarese to serve as Medicus’ Executive Chairman. Mr. Matarese will transition from his current role as the Company’s Chief Executive Officer (“CEO”) and transition day-to-day leadership and responsibilities to Medicus’ current Chief Operating Officer, Robert “Bob” Dickey, who the Board of Directors is pleased to appoint as CEO of the Company.

“We have been discussing this transition for some time, and this is a natural progression,” Mr. Matarese said. He added, “Bob has done a fantastic job leading Sales and Operations of the business since he joined, and with his background of over 20 years in the staffing space, we are thrilled for this transition. I’m highly encouraged with what I see in the Company’s future. The team is strong and I look forward to continuing to support the company as Executive Chairman.”

“Joe has done an incredible job building Medicus into one of the largest locum tenens companies in the country, and we appreciate his vision and leadership over the years,” said Peter Magas, Partner at BPOC. In partnership with management, BPOC led a recapitalization of the Company in October 2018. Pete added, “This transition is part of the Company’s long-term strategy, and we know Bob will transition seamlessly into the CEO role. Bob has invaluable experience leading rapidly growing, large staffing companies, which will be instrumental for Medicus’ next phase of growth.”

Prior to his appointment as CEO, Mr. Dickey served as Chief Operating Officer since August 2017. Before joining Medicus, Bob served as a Group President at Randstad, a global staffing organization. He has more than two decades of experience in the industry and was instrumental in the organization’s extraordinary growth.

As the Company’s Executive Chairman, Mr. Matarese will continue to serve on its Board of Directors and focus on long-term strategy and on leading strategic initiatives for the Company.

About Medicus Healthcare Solutions:

Based in Windham, New Hampshire, Medicus assists hospitals and physician groups with the recruitment and staffing of physicians on a temporary basis. Medicus works with hundreds of healthcare facilities and thousands of physicians across multiple specialties.

For more information on Medicus Healthcare Solutions, please visit https://medicushcs.com.

About BPOC:

BPOC is a Chicago-based private equity management firm founded in 1996 to invest in middle-market buy-out transactions, recapitalizations, and growth platforms exclusively in the healthcare industry. BPOC has structured, managed and realized investments on behalf of institutional and individual investors for over two decades. Since inception, BPOC has raised five funds with aggregate capital commitments of over $1.3 billion. The firm is headquartered in Chicago, IL.

For more information on BPOC, please visit http://www.bpoc.com.

Share article on social media or email:

EdgeOne Medical Again Named Top 10 Medical Device Testing and Certification Company by MedTech Outlook


EdgeOne Medical Device Test Lab

The growing complexity of differentiating medical device platforms into large pharmaceutical product portfolios is a challenge for combination product makers, and EdgeOne is proud to be a trusted development and testing partner to these health tech innovators

EdgeOne Medical, experts in critical support throughout the development and life cycle management of healthcare products, has again been recognized as one of the Top 10 Medical Device Testing Companies 2020 by Med Tech Outlook Magazine. The award list is selected by an editorial board consisting of medical equipment technology veterans and industry analysts seeking to recognize and promote companies that deliver excellent service and impact to medical device industry. EdgeOne Medical was recognized for its ISO 13485 certified and FDA compliant Medical Device and Combination Products Testing Lab that provides verification, validation and performance testing in hardware and software for global requirements.

Many of the top 50 global biopharma, medical device and combination product companies choose EdgeOne for integrated product development services. EdgeOne offers a full suite of testing services for the entire development process, including early testing for key performance characteristics, test method development and validation, verification and aging testing, and Design of Experiments (DOE) for determining design features sensitive to proposed manufacturing process conditions.

EdgeOne Medical’s CEO Lilli Zakarija, a 20-year bioscience and medical device veteran says, “We are honored to be selected again by MedTech Outlook. The growing complexity of differentiating medical device platforms into large pharmaceutical product portfolios is a challenge for combination product makers, and EdgeOne is proud to be a trusted development and testing partner to these health tech innovators.”

“EdgeOne’s mission is to improve healthcare by accelerating the development of healthcare product innovations. Being recognized for our ISO 13485 certified and FDA compliant testing services further positions EdgeOne Medical as a leader in integrated product development,” says Zakarija.

About EdgeOne Medical Inc

Leading contract development organization, EdgeOne Medical, provides critical product development support throughout the development and life cycle management of healthcare products. Several of the top 50 global biopharma and medical device companies as well as emerging bioscience and digital health organizations trust EdgeOne Medical as their cartographer for developing better healthcare technologies and therapies. Learn more at edgeonemedical.com

Share article on social media or email:

Integrative Healthcare Symposium Announced New Dates for 2021


“We are dedicated to providing the community with a reliable and beneficial in-person conference, where healthcare professionals will re-engage with peers and find inspiration for the future of integrative healthcare,” said Liz Plizga, Group Vice President, Diversified Communications.

Today, Diversified Communications, organizer of the Integrative Healthcare Symposium, has determined that the continued and long-term magnitude of the public health and safety issues caused by COVID-19 requires the postponement of the event until May 2-4, 2021 at the New York Hilton Midtown, NY.

In the last five months, the healthcare industry and community have been experiencing some of the most tumultuous, emotionally, and economically challenging times.

The new dates were carefully chosen in consideration of the situation with COVID-19, the venue availability, as well as feedback from customers and practitioners. The May 2021 edition of the Symposium will follow a new date pattern, with the exhibit hall and conference program opening on Sunday, May 2nd and ending Tuesday May 4th. The Pre-Conference day is scheduled for Saturday, May 1st.

“We are dedicated to providing the community with a reliable and beneficial in-person conference, where healthcare professionals will re-engage with peers and find inspiration for the future of integrative healthcare,” said Liz Plizga, Group Vice President, Diversified Communications.

“The health and safety of our customers, community and employees is a top priority,” added Plizga. The Integrative Healthcare Symposium team is committed to adhering to state, city, and venue guidelines and will consider additional precautions as needed, and as conditions change. Updates on health and safety information will be added on the event’s website as they become available. “We thank everyone in the industry, our vendors and partners for their continued support while we navigate this unprecedented time.”

For more information on the Integrative Healthcare Symposium and the May 2021 conference, please visit: https://www.ihsymposium.com/

About Integrative Healthcare Symposium: The Integrative Healthcare Symposium brings together multi-disciplinary practitioners and healthcare professionals dedicated to improving patient outcomes and defining the future of integrative healthcare. Attendees return to the annual conference each year to attend CME sessions, symposia, roundtable discussions, and networking events. During the three-day live event, practitioners connect with peers, synthesize findings, and ultimately take new insights and approaches back to their practices. The conference and its official media, Integrative Practitioner, represent collaboration between many generous and esteemed organizations and individuals who support the integrative healthcare model. Integrative Healthcare Symposium is produced by Diversified Communications. For more information, visit ihsymposium.com.

About Diversified Communications: Diversified Communications is a leading international media company with a portfolio of face-to-face exhibitions and conferences, online communities and digital and print publications. As producers of these market-leading products Diversified Communications connects, educates and strengthens business communities in over 15 industries including: renewable energy, healthcare, natural and organic, food and beverage, and technology. Established in 1949 and headquartered in Portland, Maine, USA with divisions and offices around the world, Diversified Communications remains a privately held, third generation, family-owned business. For more information, visit: http://www.divcom.com.

Share article on social media or email: